Isolation of an "antigen" from malignant tumours.
- 1 August 1973
- journal article
- Vol. 1, 219-23
Abstract
From a variety of human malignant neoplasms it is possible to prepare by acid extraction and chromatography a fraction with peak “antigenic” activity in the macrophage electrophoretic mobility (MEM) test for cancer. The activity is related to the presence of tryptophan. An analysis of the most active material so far prepared suggests important differences from myelin basic protein and from histones.This publication has 11 references indexed in Scilit:
- Evaluation and Development of the Macrophage Electrophoretic Mobility (MEM) Test for Malignant Disease)British Journal of Cancer, 1973
- Interaction of Hallucinogenic Drugs with Encephalitogenic Protein of MyelinNature, 1972
- Localization of Tumour Specific Antigen on External Surface of Plasma MembraneNature New Biology, 1972
- MACROPHAGE-ELECTROPHORETIC-MOBILITY (M.E.M.) TEST FOR MALIGNANT DISEASE: An Independent ConfirmationThe Lancet, 1972
- Immunological activity of blood lymphocyte fractions. A study by the macrophage electrophoretic mobility method.1972
- Lymphocyte Sensitization to Basic Protein of Brain in Malignant Neoplasia: Experiments with Serotonin and Related CompoundsNature, 1971
- Specific Lymphocyte Sensitization in Cancer: Is There a Common Antigen in Human Malignant Neoplasia?BMJ, 1971
- Amino acid sequence of the encephalitogenic basic protein from human myelinBiochemical Journal, 1971
- LYMPHOCYTE SENSITISATION: AN IN-VITRO TEST FOR CANCER ?The Lancet, 1970
- Allergic encephalomyelitis: Cleavage of the C-tryptophyl bond in the encephalitogenic basic protein from bovine myelinArchives of Biochemistry and Biophysics, 1969